A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, assessor-blind, placebo controlled study in major depressive disorder
(MDD) patients. Subjects receiving antidepressant drug (FLX) would be assigned to receive
either 18 sham / active DCEAS for in 6 weeks. Changes in the severity of depressive symptoms
over time are measured using depression rating scales. Brain glucose metabolic levels are
measured using PET at baseline and endpoint. The most intriguing and expected result might be
that acupuncture treated-patients may display comparable or even better outcomes and the
clinical improvements by acupuncture are correlated with the restoration of the activities in
the related brain regions.
Phase:
N/A
Details
Lead Sponsor:
The University of Hong Kong
Collaborators:
Kowloon Hospital, Hong Kong Queen Mary Hospital, Hong Kong Southern Medical University, China